In our study, moderately increased BC risk was defined for mutations in the Fanconi anemia genes FANCC (OR = 2.4) and FANCI (OR = 4.3), but not for FANCM (OR = 0.6), although the difference was not significant. This evidence concerns the gene FANCM and breast cancer.